Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
11.08
-0.38 (-3.32%)
At close: Sep 4, 2026, 4:00 PM EDT
10.99
-0.09 (-0.81%)
After-hours: Sep 4, 2026, 7:30 PM EDT
Corbus Pharmaceuticals Holdings Employees
Corbus Pharmaceuticals Holdings had 36 employees as of December 31, 2025. The number of employees increased by 8 or 28.57% compared to the previous year.
Employees
36
Change (1Y)
8
Growth (1Y)
28.57%
Revenue / Employee
n/a
Profits / Employee
-$2,830,639
Market Cap
214.30M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 36 | 8 | 28.57% |
| Dec 31, 2024 | 28 | 9 | 47.37% |
| Dec 31, 2023 | 19 | -14 | -42.42% |
| Dec 31, 2022 | 33 | -8 | -19.51% |
| Dec 31, 2021 | 41 | -35 | -46.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Protalix BioTherapeutics | 226 |
| Coherus Oncology | 144 |
| Voyager Therapeutics | 141 |
| Nkarta | 106 |
| Alpha Cognition | 71 |
| Armata Pharmaceuticals | 61 |
| PepGen | 57 |
| NovaBridge Biosciences | 30 |
CRBP News
- 20 days ago - Corbus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 20 days ago - Corbus Pharmaceuticals price target lowered to $33 from $34 at Mizuho - TheFly
- 4 weeks ago - Corbus Pharmaceuticals price target lowered to $48 from $52 at Oppenheimer - TheFly
- 4 weeks ago - Corbus Pharmaceuticals Holdings Earnings release: Q2 2026 - Filings
- 4 weeks ago - Corbus Pharmaceuticals Holdings Quarterly report: Q2 2026 - Filings
- 4 weeks ago - Corbus reports last patient completes last visit in CANYON-1 trial - TheFly
- 4 weeks ago - Corbus Pharmaceuticals Announces Last Patient Last Visit in CANYON-1 Study of CRB-913 for the Treatment of Obesity - GlobeNewsWire
- 5 weeks ago - Corbus Pharmaceuticals announces FDA clearance to initiate TEMPO-1 trial - TheFly